Skip to main content
Pharmafile

Is the Current EU Legal Framework for Orphan Medicines Fit for Purpose?

Autumn 2019
著者
Dr. Chris Boyle

Maria Isabel Manley, partner and head of the UK Global Life Sciences Practice, and Chris Boyle, associate, at Sidley, discuss the impact of regulatory frameworks on medicines for rare diseases.

View Article

連絡先

Boyle, Chris
パートナー

得意分野

Suggested News & Insights

2026 Momentum Food and Beverage ExchangeOctober 6-7, 2026
Events
Sidley Represents Jiangsu Hengrui in Connection With US$2.6 Billion Licensing Agreement With Novo NordiskOctober 1, 2026
Announcements
Sidley Represents Pyxis Oncology in an up to US$282.6 Million Public OfferingOctober 1, 2026
Announcements
Sidley Represents Jiangsu Nhwa Pharmaceutical in Its US$517.5 Million Licensing Transaction With SomniveraSeptember 30, 2026
Announcements
Partners Michael Resch and Smitha Stansbury Join Sidley to Expand Global Life Sciences PracticesSeptember 21, 2026
Press Releases
U.S. Department of Justice Announces Major Justice Manual Revisions on Sub-Regulatory Guidance and Dismissals of False Claims Act Qui TamsSeptember 21, 2026
Healthcare Update